Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. 1.18%246.691.3%$805.27m
IMMUImmunomedics, Inc. 0.07%85.4211.0%$697.67m
MRNAModerna, Inc. 0.61%69.890.0%$670.52m
NVAXNovavax, Inc. -4.46%108.5096.5%$600.98m
ILMNIllumina, Inc. 1.56%304.563.5%$591.87m
GILDGilead Sciences, Inc. 0.80%62.751.0%$578.72m
REGNRegeneron Pharmaceuticals, Inc. -1.70%564.312.7%$435.85m
BIIBBiogen, Inc. 2.81%280.961.6%$344.39m
VRTXVertex Pharmaceuticals, Inc. -0.37%267.181.9%$339.58m
ALXNAlexion Pharmaceuticals, Inc. -0.59%113.762.0%$283.55m
EXASEXACT Sciences Corp. 1.95%99.6020.7%$262.29m
SRNESorrento Therapeutics, Inc. 4.29%10.051.5%$251.24m
SGENSeattle Genetics, Inc. 2.58%189.736.0%$217.62m
VXRTVaxart, Inc. -6.55%6.920.0%$200.01m
MNTAMomenta Pharmaceuticals, Inc. 0.10%52.453.0%$193.77m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.